Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zenomed Healthcare is an Indian pharmaceutical contract manufacturing organization focused on formulation development, regulatory dossier support, and commercial manufacturing for originator and generic pharma customers. The company manufactures primarily solid oral and related formulations, including tablets, hard gelatin capsules, and dry syrups, and also highlights packaging capabilities such as blister, strip, and alu-alu formats. Its product coverage spans multiple therapy categories including antibiotics, anti-epileptics, antiemetics, cardiometabolic, dermatology, gastroenterology, neurology, psychiatry, urology, and pain products. Zenomed positions itself as a Schedule M GMP-certified manufacturer serving third-party and principal-to-principal manufacturing needs in India, with capabilities extending to bilayer and sustained-release tablets and an automated liquid filling, sealing, and labeling line.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zenomed Healthcare.